Edwards J - Search Results

1

GRP78 up-regulation is associated with androgen receptor status, Hsp70-Hsp90 client proteins and castrate-resistant prostate cancer.

Tan SS, Ahmad I, Bennett HL, Singh L, Nixon C, Seywright M, Barnetson RJ, Edwards J, Leung HY. Tan SS, et al. Among authors: edwards j. J Pathol. 2011 Jan;223(1):81-7. doi: 10.1002/path.2795. Epub 2010 Oct 28. J Pathol. 2011. PMID: 21125667

2

Identification of loci associated with putative recurrence genes in transitional cell carcinoma of the urinary bladder.

Edwards J, Duncan P, Going JJ, Watters AD, Grigor KM, Bartlett JM. Edwards J, et al. J Pathol. 2002 Apr;196(4):380-5. doi: 10.1002/path.1052. J Pathol. 2002. PMID: 11920732

3

Gene amplifications associated with the development of hormone-resistant prostate cancer.

Edwards J, Krishna NS, Witton CJ, Bartlett JM. Edwards J, et al. Clin Cancer Res. 2003 Nov 1;9(14):5271-81. Clin Cancer Res. 2003. PMID: 14614009

4

The role of c-Jun and c-Fos expression in androgen-independent prostate cancer.

Edwards J, Krishna NS, Mukherjee R, Bartlett JM. Edwards J, et al. J Pathol. 2004 Oct;204(2):153-8. doi: 10.1002/path.1605. J Pathol. 2004. PMID: 15378488

5

Type I receptor tyrosine kinases are associated with hormone escape in prostate cancer.

Bartlett JM, Brawley D, Grigor K, Munro AF, Dunne B, Edwards J. Bartlett JM, et al. Among authors: edwards j. J Pathol. 2005 Mar;205(4):522-9. doi: 10.1002/path.1735. J Pathol. 2005. PMID: 15685688

6

The role of HER1-HER4 and EGFRvIII in hormone-refractory prostate cancer.

Edwards J, Traynor P, Munro AF, Pirret CF, Dunne B, Bartlett JM. Edwards J, et al. Clin Cancer Res. 2006 Jan 1;12(1):123-30. doi: 10.1158/1078-0432.CCR-05-1445. Clin Cancer Res. 2006. PMID: 16397033 Free article.

7

Editorial comment on: Increased expression of tumor-associated trypsin inhibitor, TATI, in prostate cancer and in androgen-independent 22Rv1 cells.

Edwards J, Leung HY. Edwards J, et al. Eur Urol. 2007 Dec;52(6):1680-1. doi: 10.1016/j.eururo.2007.01.098. Eur Urol. 2007. PMID: 17306442 No abstract available.

8

Bad expression influences time to androgen escape in prostate cancer.

Teo K, Gemmell L, Mukherjee R, Traynor P, Edwards J. Teo K, et al. Among authors: edwards j. BJU Int. 2007 Sep;100(3):691-6. doi: 10.1111/j.1464-410X.2007.07001.x. Epub 2007 Jun 2. BJU Int. 2007. PMID: 17542986

9

Expression of tumor necrosis factor alpha converting enzyme in endocrine cancers.

Kirkegaard T, Naresh A, Sabine VS, Tovey SM, Edwards J, Dunne B, Cooke TG, Jones FE, Bartlett JM. Kirkegaard T, et al. Among authors: edwards j. Am J Clin Pathol. 2008 May;129(5):735-43. doi: 10.1309/N6YB6YDVF58YCNHN. Am J Clin Pathol. 2008. PMID: 18426733

10

A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth.

Guo Z, Yang X, Sun F, Jiang R, Linn DE, Chen H, Chen H, Kong X, Melamed J, Tepper CG, Kung HJ, Brodie AM, Edwards J, Qiu Y. Guo Z, et al. Among authors: edwards j. Cancer Res. 2009 Mar 15;69(6):2305-13. doi: 10.1158/0008-5472.CAN-08-3795. Epub 2009 Feb 24. Cancer Res. 2009. PMID: 19244107 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,141 results

Search Page

Filters